Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Pacira Pharmaceuticals buy Barclays PLC

Pacira Pharmaceuticals
Start price
€26.80
08.05.24 / 50%
Target price
€35.35
08.05.25
Performance (%)
6.72%
Price
€28.00
17.05.24
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 6.72%. This prediction currently runs until 08.05.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w
Pacira Pharmaceuticals 3.704%
iShares Core DAX® -0.383%
iShares Nasdaq 100 1.248%
iShares Nikkei 225® 0.525%
iShares S&P 500 0.640%

Comments by Barclays_PLC for this prediction

In the thread Pacira Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 6.72%
Target price 35.351
Change
Ends at 08.05.25

Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Barclays PLC from $40.00 to $38.00. They now have an "overweight" rating on the stock.
Ratings data for PCRX provided by MarketBeat

Barclays PLC 
0
Report Share
08.05.24

Stopped prediction by Barclays_PLC for Pacira Pharmaceuticals

buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€26.20
23.10.23
€53.51
23.10.24
9.16%
17.05.24

Barclays PLC 
23.10.23 50%